Quris-AI

Quris-AI is the world's first BioAI clinical prediction platform, ensuring the safety of new drugs. The company has revolutionized the drug development process by being the first to conduct clinical trials on a chip—testing thousands of novel drug candidates on hundreds of miniaturized "patient-on-a-chip" models. Its fully automated, self-training artificial intelligence platform accurately predicts the clinical safety and efficacy of new drugs faster and more cost-effectively than ever before, while minimizing animal testing. Quris-AI, headquartered in Boston and Israel, is backed by strategic biotechnology and big data investors and led by a seasoned team of AI and medical research giants.